Click-to-Release Biotech Patent for Proteins and Peptides
Summary
The USPTO published patent application US20260091124A1 by inventor Michael Lukesch for a click-to-release technology involving modified peptides or proteins combined with bioorthogonally modified drugs. The application, filed September 20, 2023, and published April 2, 2026, covers bioorthogonal functional groups that enable targeted drug delivery systems for therapeutic applications.
What changed
The USPTO published a patent application for a combination technology involving modified peptides or proteins with bioorthogonal functional groups paired with complementary drug modifications. Application US20260091124A1 claims priority to European Application No. 19113365 and covers CPC classifications in drug conjugates (A61K 47/6851, A61K 47/6803), antibodies (C07K 16/3092), and peptide modifications (C07K 2317/569). The invention enables controlled drug release through bioorthogonal chemistry.
This is a patent publication notice, not a regulatory requirement. Inventors, pharmaceutical companies, and biotech researchers should review the claims to assess freedom-to-operate, potential licensing opportunities, or competitive landscape implications. No compliance actions, deadlines, or penalties are associated with this publication.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CLICK-TO-RELEASE ON PROTEINS AND PEPTIDES
Application US20260091124A1 Kind: A1 Apr 02, 2026
Inventors
Michael LUKESCH
Abstract
The invention relates to a combination of a modified peptide or protein comprising one or more bioorthogonal functional group, and a drug which is modified with one or more bioorthogonal functional group which is complementary to the bioorthogonal group of the peptide or protein.
CPC Classifications
A61K 47/6851 A61K 47/6803 C07K 16/3092 C07K 2317/569
Filing Date
2023-09-20
Application No.
19113365
Named provisions
Related changes
Get daily alerts for ChangeBridge: Patent Apps - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Peptides (C07K) publishes new changes.